Mechanism of Action
Kesimpta ® is a targeted and precisely delivered B-cell therapy 1,5
B-cells play a central role in the pathogenesis of MS 4
KESIMPTA ® (ofatumumab) is a fully human anti...
B-cells play a central role in the pathogenesis of MS 4
KESIMPTA ® (ofatumumab) is a fully human anti...
Sacubitril/valsartan, a first-in-class ARNI, delivers simultaneous inhibition of neprilysin and blockade of the AT1 receptor. Sacubitril/valsartan is a sodium salt complex comprising sacubitril (AHU377), a prodrug, which is further metabolized to the...
Cosentyx (secukinumab) is a fully human IgG1/κ monoclonal antibody that selectively binds to and neutralizes the proinflammatory cytokine interleukin-17A (IL-17A). 1 Cosentyx works by targeting IL-17A and inhibiting its interaction with...